Varenicline
- Product NDC
- 50090-8088
- Requested package NDC
- 50090-8088-0
- 11-digit product format
- 500908088
- Labeler code
- 50090
- Product ID
- 50090-8088_9aa5b5fe-9ac9-4779-8080-c9bfd42e405b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Varenicline
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA215048
- Marketing category
- ANDA
- Marketing start
- 2024-12-10
- Substance
- VARENICLINE TARTRATE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Partial Cholinergic Nicotinic Agonist [EPC], Partial Cholinergic Nicotinic Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215048-001 | VARENICLINE TARTRATE | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | |
| A215048-002 | VARENICLINE TARTRATE | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A215048-001 | AB |
| A215048-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | 2680178bc6a6… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215048-001 | VARENICLINE TARTRATE | EQ 0.5MG BASE | TABLET / ORAL | AB | 2024-12-09 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215048-002 | VARENICLINE TARTRATE | EQ 1MG BASE | TABLET / ORAL | AB | 2024-12-09 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A215048-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A215048-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A215048-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A215048-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A215048-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A215048-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215048-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215048-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A215048-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A215048-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215048-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215048-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215048-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215048-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215048-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215048-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215048-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215048-002 | AB | 1 | 2680178bc6a6… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215048-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215048-002 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Varenicline
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| VARENICLINE TARTRATE | .5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 82269ASB48 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 636671 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 09e23664-936d-4c7f-86e5-5f924cb0c8b4 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Varenicline | VARENICLINE | A-S Medication Solutions | 09e23664-936d-4c7f-86e5-5f924cb0c8b4 | 2026-09-21 | Warnings, Adverse reactions | 215048 ANDA215048 50090-8088-0 50090-8088 50090808800 |
| Varenicline | VARENICLINE | Macleods Pharmaceuticals Limited | c325d582-8f43-40ea-b348-87837de97a07 | 2025-09-18 | Warnings, Adverse reactions | 215048 ANDA215048 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 50090-8088-0 | 50090808800 | 1 TABLET, FILM COATED in 1 KIT (50090-8088-0) | 2026-09-21 | No | No | Current |